ArticleJournal of endocrinological investigation2023

Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.

J Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.